Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization
Authors
Keywords
-
Journal
AGING CELL
Volume 21, Issue 4, Pages -
Publisher
Wiley
Online
2022-03-28
DOI
10.1111/acel.13596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin treatment in late middle age improves cognitive function with alleviation of microglial activation and enhancement of autophagy in the hippocampus
- (2021) Maheedhar Kodali et al. AGING CELL
- Senolytic combination of Dasatinib and Quercetin alleviates intestinal senescence and inflammation and modulates the gut microbiome in aged mice
- (2021) Tatiana Dandolini Saccon et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity
- (2021) Yihai Liu et al. Lipids in Health and Disease
- Metformin-Induced MicroRNA-34a-3p Downregulation Alleviates Senescence in Human Dental Pulp Stem Cells by Targeting CAB39 through the AMPK/mTOR Signaling Pathway
- (2021) Shuo Zhang et al. Stem Cells International
- Metformin inhibits chronic kidney disease‐induced DNA damage and senescence of mesenchymal stem cells
- (2021) Hyoungnae Kim et al. AGING CELL
- Chronic metformin treatment decreases cardiac injury during ischemia-reperfusion by attenuating endoplasmic reticulum stress with improved mitochondrial function
- (2021) Qun Chen et al. Aging-US
- Metformin Attenuates ROS via FOXO3 Activation in Immune Cells
- (2021) Jelka Hartwig et al. Frontiers in Immunology
- Moving geroscience from the bench to clinical care and health policy
- (2021) Felipe Sierra et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Acarbose improved survival for Apc +/Min mice
- (2020) Sherry G. Dodds et al. AGING CELL
- Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR
- (2020) Xiaofeng Feng et al. Aging-US
- Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice
- (2020) Marcelo B. Cavalcante et al. Aging-US
- Cardiovascular risk following metformin treatment in patients with type 2 diabetes mellitus: Results from meta-analysis
- (2020) Kui Zhang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin reduces aging-related leaky gut and improves cognitive function by beneficially modulating gut microbiome/goblet cell/mucin axis
- (2020) Shokouh Ahmadi et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Senolytics (DQ) Mitigates Radiation Ulcers by Removing Senescent Cells
- (2020) Huilan Wang et al. Frontiers in Oncology
- Benefits of Metformin in Attenuating the Hallmarks of Aging
- (2020) Ameya S. Kulkarni et al. Cell Metabolism
- Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation
- (2020) Leena P. Bharath et al. Cell Metabolism
- SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
- (2020) Anton I. Korbut et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta‐analysis
- (2020) Kang Xiao et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis
- (2020) Jian-Bo Zhou et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Transient metabolic improvement in obese mice treated with navitoclax or dasatinib/quercetin
- (2020) Arantzazu Sierra-Ramirez et al. Aging-US
- Acarbose protects from central and peripheral metabolic imbalance induced by benzene exposure
- (2020) L.K. Debarba et al. BRAIN BEHAVIOR AND IMMUNITY
- SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
- (2020) Issei Tomita et al. Cell Metabolism
- Ageing‐associated increase in SGLT2 disrupts mitochondrial/sarcoplasmic reticulum Ca 2+ homeostasis and promotes cardiac dysfunction
- (2020) Yusuf Olgar et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Aspirin protects melanocytes and keratinocytes against UVB-induced DNA damage in vivo
- (2020) Hafeez Rahman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Protective Effect of Metformin against Hydrogen Peroxide-Induced Oxidative Damage in Human Retinal Pigment Epithelial (RPE) Cells by Enhancing Autophagy through Activation of AMPK Pathway
- (2020) Xia Zhao et al. Oxidative Medicine and Cellular Longevity
- Metformin improves cognition of aged mice by promoting cerebral angiogenesis and neurogenesis
- (2020) Xiaoqi Zhu et al. Aging-US
- Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study
- (2020) Katherine Samaras et al. DIABETES CARE
- Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging
- (2020) Young-Kyoung Ryu et al. NEUROPHARMACOLOGY
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
- (2020) Jasper Iske et al. Nature Communications
- Canagliflozin extends lifespan in genetically heterogeneous male but not female mice
- (2020) Richard A. Miller et al. JCI Insight
- Acarbose has sex-dependent and independent effects on age-related physical function, cardiac health and lipid biology
- (2020) Jonathan J Herrera et al. JCI Insight
- Acarbose ameliorates spontaneous type‑2 diabetes in db/db mice by inhibiting PDX‑1 methylation
- (2020) Diyi Zhou et al. Molecular Medicine Reports
- Autophagy-mediated metabolic effects of aspirin
- (2020) Francesca Castoldi et al. Cell Death Discovery
- Association of metformin use with ovarian cancer incidence and prognosis: a systematic review and meta-analysis
- (2019) Jinghua Shi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
- (2019) Jamie N. Justice et al. EBioMedicine
- Rapamycin and Alzheimer’s disease: Time for a clinical trial?
- (2019) Matt Kaeberlein et al. Science Translational Medicine
- Frailty index as a biomarker of lifespan and healthspan: focus on pharmacological interventions
- (2019) Dushani L. Palliyaguru et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis
- (2019) Chien-Boon Jong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Acarbose improves health and lifespan in aging HET3 mice
- (2019) David E. Harrison et al. AGING CELL
- Metformin prescription and aortic aneurysm: systematic review and meta-analysis
- (2019) Xinyu Yu et al. HEART
- Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model
- (2019) Peisu Zhang et al. NATURE NEUROSCIENCE
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice
- (2019) Byron J Smith et al. BMC MICROBIOLOGY
- Rapamycin modulates tissue aging and lifespan independently of the gut microbiota in Drosophila
- (2019) Joseph M. Schinaman et al. Scientific Reports
- Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double‐blind, placebo‐controlled, multicenter trial: The MASTERS trial
- (2019) R. Grace Walton et al. AGING CELL
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
- (2019) LaTonya J. Hickson et al. EBioMedicine
- Rapamycin for longevity: opinion article
- (2019) Mikhail V. Blagosklonny Aging-US
- Testing the Geroscience Hypothesis: Early Days
- (2019) Stephen B Kritchevsky et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults
- (2018) Ameya S Kulkarni et al. AGING CELL
- Gene Expression-Based Drug Repurposing to Target Ageing
- (2018) Handan Melike Dönertaş et al. AGING CELL
- A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
- (2018) Ellen Kraig et al. EXPERIMENTAL GERONTOLOGY
- Aspirin induces Lysosomal biogenesis and attenuates Amyloid plaque pathology in a mouse model of Alzheimer's disease via PPARα
- (2018) Sujyoti Chandra et al. JOURNAL OF NEUROSCIENCE
- SGLT-2 Inhibitors and Cardiovascular Risk
- (2018) Matthew A. Cavender et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Senolytics improve physical function and increase lifespan in old age
- (2018) Ming Xu et al. NATURE MEDICINE
- TORC1 inhibition enhances immune function and reduces infections in the elderly
- (2018) Joan B. Mannick et al. Science Translational Medicine
- Aspirin Recapitulates Features of Caloric Restriction
- (2018) Federico Pietrocola et al. Cell Reports
- Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus
- (2018) Chin‐Hsiao Tseng Journal of the American Heart Association
- Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
- (2018) Hao Zhou et al. Redox Biology
- N-acetyl L-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging
- (2018) Geetika Garg et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
- (2018) Jared M. Campbell et al. JOURNAL OF ALZHEIMERS DISEASE
- Chronic treatment with the ACE inhibitor enalapril attenuates the development of frailty and differentially modifies pro-and anti-inflammatory cytokines in aging male and female C57BL/6 mice
- (2018) Kaitlyn Keller et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
- (2018) John J. McNeil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- N-acetylcysteine Treatment Reduces Age-related Hearing Loss and Memory Impairment in the Senescence-Accelerated Prone 8 (SAMP8) Mouse Model
- (2018) Aurore Marie et al. Aging and Disease
- Rapamycin improves healthspan but not inflammaging in nfκb1 −/− mice
- (2018) Clara Correia-Melo et al. AGING CELL
- Rapamycin inhibits proliferation and induces autophagy in human neuroblastoma cells
- (2018) Xiaokun Lin et al. BIOSCIENCE REPORTS
- A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats
- (2018) Aysegul Durak et al. Cardiovascular Diabetology
- Rapamycin alleviates proinflammatory cytokines and nociceptive behavior induced by chemotherapeutic paclitaxel
- (2018) Xiaoli Zhang et al. NEUROLOGICAL RESEARCH
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- N-Acetylcysteine Prevents the Spatial Memory Deficits and the Redox-Dependent RyR2 Decrease Displayed by an Alzheimer’s Disease Rat Model
- (2018) Jamileth More et al. Frontiers in Aging Neuroscience
- mTORC1 inhibition with rapamycin exacerbates adipose tissue inflammation in obese mice and dissociates macrophage phenotype from function
- (2017) Vivian A. Paschoal et al. IMMUNOBIOLOGY
- Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
- (2017) Gordon K. Wilcock et al. JOURNAL OF ALZHEIMERS DISEASE
- Targeting cellular senescence prevents age-related bone loss in mice
- (2017) Joshua N Farr et al. NATURE MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin II receptor blockers induce autophagy in prostate cancer cells
- (2017) Yunseo Woo et al. Oncology Letters
- Cellular senescence mediates fibrotic pulmonary disease
- (2017) Marissa J. Schafer et al. Nature Communications
- Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
- (2017) Rury R Holman et al. Lancet Diabetes & Endocrinology
- Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men
- (2017) Nahid Rianon et al. Archives of Osteoporosis
- NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse Model
- (2017) Nancy L. Nadon et al. EBioMedicine
- Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
- (2017) Viktor Martyanov et al. PLoS One
- Anti-Aging Potentials of Methylene Blue for Human Skin Longevity
- (2017) Zheng-Mei Xiong et al. Scientific Reports
- Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer
- (2016) Randy Strong et al. AGING CELL
- Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
- (2016) Carolyn M. Roos et al. AGING CELL
- Rapamycin alleviates oxidative stress-induced damage in rat erythrocytes
- (2016) Abhishek Kumar Singh et al. Biochemistry and Cell Biology
- Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study
- (2016) Huang-Tz Ou et al. Cardiovascular Diabetology
- Metformin as a Tool to Target Aging
- (2016) Nir Barzilai et al. Cell Metabolism
- N -acetylcysteine protects memory decline induced by streptozotocin in mice
- (2016) Michael Costa et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register
- (2016) Nils Ekström et al. DIABETES OBESITY & METABOLISM
- The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
- (2016) Ji Hye Han et al. DIABETOLOGIA
- Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
- (2016) José A. Luchsinger et al. JOURNAL OF ALZHEIMERS DISEASE
- Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension
- (2016) Leo Akioyamen et al. Journal of the American Society of Hypertension
- Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience
- (2016) Derek M. Huffman et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials
- (2016) Sripal Bangalore et al. MAYO CLINIC PROCEEDINGS
- The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/−Mice
- (2016) Weiling Leng et al. MEDIATORS OF INFLAMMATION
- Articulating the Case for the Longevity Dividend
- (2016) S. Jay Olshansky Cold Spring Harbor Perspectives in Medicine
- Metformin: A Hopeful Promise in Aging Research
- (2016) Marta G. Novelle et al. Cold Spring Harbor Perspectives in Medicine
- Effect of Acarbose on Long-Term Prognosis in Acute Coronary Syndromes Patients with Newly Diagnosed Impaired Glucose Tolerance
- (2016) Peng Yun et al. Journal of Diabetes Research
- Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
- (2016) Yao-Yao Zhou et al. Scientific Reports
- Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria
- (2015) Zheng-Mei Xiong et al. AGING CELL
- The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
- (2015) Yi Zhu et al. AGING CELL
- Chronic acarbose treatment alleviates age-related behavioral and biochemical changes in SAMP8 mice
- (2015) Jing-Jing Tong et al. BEHAVIOURAL BRAIN RESEARCH
- Long-term acarbose administration alleviating the impairment of spatial learning and memory in the SAMP8 mice was associated with alleviated reduction of insulin system and acetylated H4K8
- (2015) Wen-Wen Yan et al. BRAIN RESEARCH
- Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis
- (2015) Yi-Ning Dai et al. CANCER CAUSES & CONTROL
- Impact of renin–angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysis
- (2015) Jasper J. Brugts et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of blood pressure lowering on outcome incidence in hypertension
- (2015) Costas Thomopoulos et al. JOURNAL OF HYPERTENSION
- Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer’s Disease Mouse Model
- (2015) Aya Zakaria et al. MOLECULAR NEUROBIOLOGY
- MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
- (2015) Remi-Martin Laberge et al. NATURE CELL BIOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
- (2014) S. Gandini et al. Cancer Prevention Research
- Geroscience: Linking Aging to Chronic Disease
- (2014) Brian K. Kennedy et al. CELL
- Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
- (2014) C. A. Bannister et al. DIABETES OBESITY & METABOLISM
- Advances in Geroscience: Impact on Healthspan and Chronic Disease
- (2014) J. B. Burch et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis
- (2014) Chin Cheng et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- mTOR inhibition improves immune function in the elderly
- (2014) J. B. Mannick et al. Science Translational Medicine
- Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium
- (2014) O V Leontieva et al. Cell Death & Disease
- Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males
- (2013) David E. Harrison et al. AGING CELL
- Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation
- (2013) Olga Moiseeva et al. AGING CELL
- Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
- (2013) Richard A. Miller et al. AGING CELL
- Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts
- (2013) Bidisha Saha et al. AGING CELL
- The Hallmarks of Aging
- (2013) Carlos López-Otín et al. CELL
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
- (2013) E. M. Moore et al. DIABETES CARE
- Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
- (2013) Suzanne Oparil et al. HYPERTENSION
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- Rapamycin Reduces Reactive Oxygen Species in Cultured Human Corneal Endothelial Cells
- (2012) Young Joo Shin et al. CURRENT EYE RESEARCH
- The Critical Role of Metabolic Pathways in Aging
- (2012) N. Barzilai et al. DIABETES
- Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2012) J. Hong et al. DIABETES CARE
- Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
- (2012) R. J. Stevens et al. DIABETOLOGIA
- Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients
- (2012) L. C. van Vark et al. EUROPEAN HEART JOURNAL
- Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan
- (2012) Chin-Hsiao Tseng EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Delay in oocyte aging in mice by the antioxidant N-acetyl-l-cysteine (NAC)
- (2012) Jinmiao Liu et al. HUMAN REPRODUCTION
- A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure
- (2012) Gianluigi Savarese et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
- (2012) Patrick Imfeld et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake
- (2012) Ömer H. Yilmaz et al. NATURE
- N-acetylcysteine reverses existing cognitive impairment and increased oxidative stress in glutamate transporter type 3 deficient mice
- (2012) L. Cao et al. NEUROSCIENCE
- Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
- (2012) Masato Hosokawa et al. PLoS One
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
- (2012) D. W. Lamming et al. SCIENCE
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
- (2012) D. Caldeira et al. BMJ-British Medical Journal
- Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials
- (2011) G. Tocci et al. AMERICAN JOURNAL OF HYPERTENSION
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Effects of renin–angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis
- (2011) Yoko M. Nakao et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice
- (2010) Chong Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Life Extension by Diet Restriction and N-Acetyl-L-Cysteine in Genetically Heterogeneous Mice
- (2010) K. Flurkey et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
- (2010) Richard A. Miller et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- The mTOR Inhibitor Rapamycin Suppresses DNA Double-Strand Break Repair
- (2010) Honghong Chen et al. RADIATION RESEARCH
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension
- (2009) Kaycee M. Sink et al. ARCHIVES OF INTERNAL MEDICINE
- Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats
- (2009) Edson Lucas Santos et al. BIOCHEMICAL PHARMACOLOGY
- Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
- (2009) G. W.D. Landman et al. DIABETES CARE
- Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice
- (2008) Randy Strong et al. AGING CELL
- Systemic exposure of everolimus after stent implantation: A pharmacokinetic study
- (2008) Marcus Wiemer et al. AMERICAN HEART JOURNAL
- Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging
- (2008) Hélène Bulckaen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy
- (2008) Ingrid Os et al. HYPERTENSION
- Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways
- (2007) Hani Atamna et al. FASEB JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now